Skip to main content
. Author manuscript; available in PMC: 2022 Oct 26.
Published in final edited form as: Acta Biomater. 2019 Feb 26;88:211–223. doi: 10.1016/j.actbio.2019.02.037

Table 1.

Formulations used in back, under-graft, and footpad injections.

Testa
EAK Controlb
Saline Controlc
Normal Graft Normal Graft Normal graft
EAK 800 μg 200 μg n.d. 200 μg n/a n/a
pG_EAK 30.4 μg 7.6 μg n.d. n/a n/a n/a
IgG 45 μg 11.2 μg n.d. 11.2 μg 45 μg 11.2 μg
Volumed 207.4 μL 36.7 μL n.d. 36.7 μL 207.4 μL 36.7 μL

nd: not done

n/a: not applicable

a

“System” formulation used in experiments shown in Figs. 5 and 6.

b

“Control” formulation used in experiments shown in Fig. 6.

c

“Control” formulation used in experiments shown in Figs. 5 and 6.

d

Injection volume